The company's operational performance remains deeply negative, with a $3.9 million operating loss reported in 2025Q3 and a combined ratio that reached 176.8% in 2025Q2.
| Revenue | 13.12M | 14.05M | 13.73M | 11.76M | 9.71M | 7.3M | 4.45M | 20.65K | 39.07K | 18.9K | 75.6K | 213.13K | 43.4K |
| Revenue Growth % | -6.84% | 2.35% | 16.75% | 21.13% | 33.07% | 63.95% | 21453.44% | -47.14% | 106.71% | -75% | -64.53% | 391.08% | - |
| Medical Costs & Claims | 15.02M | 11.42M | 11.24M | 10.65M | 7.1M | 5.22M | 3.02M | 101.89K | 3.08K | 19.04K | 114.67K | 89.83K | 67.27K |
| Medical Cost Ratio % | 114.49% | 81.23% | 81.82% | 90.54% | 73.12% | 71.59% | 67.9% | 493.43% | 7.87% | 100.75% | 151.67% | 42.15% | 155% |
| Gross Profit | -1.9M | 2.64M | 2.5M | 1.11M | 2.61M | 2.07M | 1.43M | -81.24K | 35.99K | -141 | -39.06K | 123.3K | -23.87K |
| Gross Margin % | -14.49% | 18.77% | 18.18% | 9.46% | 26.88% | 28.41% | 32.1% | -393.43% | 92.13% | -0.75% | -51.67% | 57.85% | -55% |
| Gross Profit Growth % | - | 5.69% | 124.28% | -57.36% | 25.9% | 45.12% | 1858.33% | -325.72% | 25626.95% | 99.64% | -131.68% | 616.53% | - |
| Operating Expenses | 6.8M | 10.33M | 16.38M | 7.69M | 5.52M | 5.7M | 4.53M | 1.44M | 501.32K | 833.4K | 591.06K | 466.88K | 275.75K |
| OpEx / Revenue % | 51.82% | 73.52% | 119.25% | 65.41% | 56.87% | 78.11% | 101.83% | 6963.33% | 1283.19% | 4409.55% | 781.79% | 219.06% | 635.35% |
| Depreciation & Amortization | 1.38M | 1.79M | 2.61M | 2.56M | 1.61M | 1.33M | 727.98K | 1.07M | 504.39K | 852.45K | 339.19K | 271.29K | 216.06K |
| Combined Ratio % | 166.31% | 154.75% | 201.07% | 155.95% | 129.99% | 149.7% | 169.74% | 7456.76% | 1291.06% | 4510.3% | 933.46% | 261.2% | 790.35% |
| Operating Income | -8.7M | -7.7M | -13.88M | -6.58M | -2.91M | -3.63M | -3.1M | 88.42K | -960.56K | -833.55K | -630.13K | -343.58K | -299.62K |
| Operating Margin % | -66.31% | -54.75% | -101.07% | -55.95% | -29.99% | -49.7% | -69.74% | 428.18% | -2458.7% | -4410.3% | -833.46% | -161.2% | -690.35% |
| Operating Income Growth % | - | 44.55% | -110.91% | -125.96% | 19.7% | -16.85% | -3610.46% | 109.2% | -15.24% | -32.28% | -83.4% | -14.67% | - |
| EBITDA | -7.32M | -5.91M | -11.27M | -4.02M | -1.31M | -2.3M | -2.38M | 1.16M | -456.17K | 18.9K | -290.94K | -72.29K | -83.56K |
| EBITDA Margin % | -55.79% | -42.05% | -82.07% | -34.15% | -13.44% | -31.54% | -53.38% | 5613.11% | -1167.64% | 100% | -384.82% | -33.92% | -192.52% |
| Interest Expense | 1.27M | 1.58M | 1.66M | 918.03K | 0 | 0 | 0 | 0 | 179.66K | 0 | 0 | 0 | 0 |
| Non-Operating Income | 39.06K | -207.34K | -5.51M | -29.06M | 0 | 0 | 0 | 290.26K | 1.44M | 0 | 0 | 0 | 0 |
| Pretax Income | -7M | -9.07M | -10.03M | 21.56M | -21.1M | -3.68M | -3.5M | -961.62K | -2.58M | -833.55K | -623.93K | -343.58K | -299.62K |
| Pretax Margin % | -53.39% | -64.55% | -73.01% | 183.32% | -217.28% | -50.45% | -78.54% | -4656.76% | -6599.85% | -4410.3% | -825.26% | -161.2% | -690.35% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.05M | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 109.19% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -7M | -9.07M | -12.01M | 6.47M | -21.1M | -3.68M | -3.5M | 421.75K | -2.58M | -833.55K | -623.93K | -343.58K | -299.62K |
| Net Margin % | -53.39% | -64.55% | -87.46% | 54.98% | -217.28% | -50.45% | -78.54% | 2042.38% | -6599.85% | -4410.3% | -825.26% | -161.2% | -690.35% |
| Net Income Growth % | 58.07% | 24.47% | -285.74% | 130.65% | -473.11% | -5.32% | -928.8% | 116.36% | -209.33% | -33.6% | -81.6% | -14.67% | - |
| EPS (Diluted) | -1.20 | -9.01 | -10.23 | 31.63 | -57.57 | -8.16 | -18.22 | 6723.61 | -115.52 | -37.79 | -28.80 | -16.65 | -15.60 |
| EPS Growth % | -386.04% | 11.93% | -132.34% | 154.94% | -605.51% | 55.21% | -100.27% | 5920.3% | -205.69% | -31.22% | -72.97% | -6.73% | - |
| EPS (Basic) | - | -9.01 | -10.23 | 31.63 | -57.57 | -8.16 | -18.22 | 6723.61 | -115.52 | -37.79 | -28.80 | -16.65 | -15.60 |
| Diluted Shares Outstanding | 5.83M | 1.01M | 1.17M | 1.09M | 673.14K | 390.87K | 191.85K | 62.73K | 22.32K | 22.06K | 21.67K | 20.64K | 19.2K |
Severe liquidity and solvency constraints
As indicated by the most recent quarterly filings, Reliance Global Group's revenue growth has turned negative, with a 27.5% decline in 2025Q3, suggesting that the company's acquisition-heavy strategy is failing to generate the necessary organic momentum to offset churn in its core insurance brokerage segments.
The persistent decline in top-line performance suggests that the company's reliance on inorganic growth through agency roll-ups is not yielding the expected scale benefits. Investors should monitor whether this contraction reflects a broader loss of market share in the competitive trucking and personal lines niches or simply an inability to integrate new acquisitions effectively.
Based on reported financial data, the company's combined ratio has frequently exceeded 100%, peaking at 176.8% in 2025Q2, which highlights a fundamental inability to maintain underwriting discipline while simultaneously managing the high fixed-cost burden associated with its digital distribution platform and corporate overhead.
The consistent failure to achieve a combined ratio below the break-even threshold suggests that the current business model is structurally unprofitable. The volatility in these ratios implies that the company lacks the pricing power or operational efficiency required to absorb claims volatility, leaving it highly exposed to underwriting losses.
According to the provided income statement data, operating margins have remained consistently negative, with the company reporting a $3.9 million operating loss in 2025Q3, indicating that the firm has yet to achieve the necessary scale to dilute its significant fixed personnel and technological development expenses.
The disconnect between revenue generation and operating costs suggests that the company's infrastructure is oversized relative to its current premium volume. This lack of operating leverage warrants further investigation into whether the digital platform, 5MinuteInsure.com, is providing any tangible cost-saving benefits or if it is merely adding to the company's cash burn.
As reported in recent financial statements, the company's cash position has dwindled to approximately $372,695, a figure that appears dangerously low when contrasted against a TTM net loss exceeding $9 million, suggesting that the firm may face imminent liquidity challenges that could force dilutive financing or asset sales.
The extreme disparity between the company's cash reserves and its ongoing operating losses suggests that the current trajectory is unsustainable without external capital intervention. Investors should be wary of the potential for significant equity dilution or the impairment of intangible assets, which could further erode the company's already strained balance sheet.
Quick answers to the most common questions about buying RELI stock.
For fiscal year 2024, Reliance Global Group, Inc. (RELI) reported total revenue of $14.1M. This represents a 32282.6% increase compared to $0.0M in 2013.
Reliance Global Group, Inc. (RELI) reported a net loss of $9.1M for the fiscal year ending 2024.
Reliance Global Group, Inc. (RELI) reported an operating income of $-7.7M, resulting in an operating profit margin of -54.8%. This margin reflects the operational efficiency of the business before interest and taxes.
Reliance Global Group, Inc. (RELI) generated $2.6M in gross profit for the year, representing a gross profit margin of 18.8%. This demonstrates the company's core pricing power and production efficiency.